Evidence map›Paper›PMID 30675319›Full record

ArticleHereditary cancer in clinical practice2019

BRCA mutation screening and patterns among high-risk Lebanese subjects.

Chantal Farra, Christelle Dagher, Rebecca Badra, Miza Salim Hammoud, Raafat Alameddine, Johnny Awwad, Muhieddine Seoud, Jaber Abbas, Fouad Boulos, Nagi El Saghir and 1 more

Open access · goldAbstract read
In one paragraph

Article in Hereditary cancer in clinical practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Patterns and Prevalence of GermlineJournal of oncology · 2020
    Article
  7. Article
  8. Review
  9. Article
  10. Cancer Genetics in the Arab World.Technology in cancer research & treatment
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Chantal Farra1Medical Genetics Unit and Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Christelle Dagher2Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Rebecca Badra1Medical Genetics Unit and Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Miza Salim Hammoud2Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Raafat Alameddine2Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Johnny Awwad3Department of Obstetrics and Gynecology, American University of Beirut Medical Center, Beirut, Lebanon.
Muhieddine Seoud3Department of Obstetrics and Gynecology, American University of Beirut Medical Center, Beirut, Lebanon.
Jaber Abbas4Department of Surgery, American University of Beirut Medical Center, Beirut, Lebanon.
Fouad Boulos1Medical Genetics Unit and Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Nagi El Saghir2Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Deborah Mukherji2Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.ORCID 0000-0002-0192-5828
American University of Beirut Medical Center · LB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious studies have suggested that the prevalence of

methodsWe retrospectively reviewed the cases of all individuals undergoing

resultsTwo-hundred eighty one individuals were referred for testing. The prevalence of mutated

conclusionThe

Indexed as

BRCA1BRCA2FamilialLebanonManchester score

Identifiers

PMID30675319
PMCPMC6339325
OpenAlexW2911919216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.